You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-cell

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Fukuoka (LY3526318, Placebo, Iohexol)

Withdrawn
  • Healthy
  • Fukuoka, Japan
    Souseikai Fukuoka Mirai Hospital
Jan 6, 2023

Acute Lymphoid Leukemia, Acute Myeloid Leukemia in Children Trial in Tours (Biological sampling in patients, Biological sampling

Not yet recruiting
  • Acute Lymphoid Leukemia
  • Acute Myeloid Leukemia in Children
  • Biological sampling in patients
  • Biological sampling in control patients
  • Tours, France
  • +2 more
Mar 17, 2023

Immune Function Trial in Seoul, Suwon-si (Lactococcus lactis, maltodextrin)

Recruiting
  • Immune Function
  • Lactococcus lactis
  • maltodextrin
  • Seoul, Korea, Republic of
  • +1 more
Jan 31, 2023

Lymphoma, High-Grade Trial in Moscow (R-DA-EPOCH-21, R-BL-M-04, R-DA-EPOCH-21 + auto-SCT)

Recruiting
  • Lymphoma, High-Grade
  • Moscow, Russian Federation
    National Research Center for Hematology
Mar 26, 2018

Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung

Recruiting
  • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Multiple Myeloma, Lymphoma, Engagement, Patient Trial (Grastofil®, Lapelga)

Not yet recruiting
  • Multiple Myeloma
  • +3 more
  • (no location specified)
Oct 30, 2023

Sexually Transmitted Infections With Mycoplasma Genitalium:

Recruiting
  • Anorectal Infection
    • Paris, France
      Groupe Hospitalier Paris Saint-Joseph
    Jun 29, 2022

    Renal Cell Carcinoma Trial (Neoadjuvant Lenvatinib, Neoadjuvant Pembrolizumab, Radical nephrectomy, IVC thrombectomy,

    Not yet recruiting
    • Renal Cell Carcinoma
    • Neoadjuvant Lenvatinib
    • +3 more
    • (no location specified)
    Dec 23, 2022

    Plantar Wart Trial (intralesional combined digoxin and furosemide, intralesional injection of 5- Fluorouracil, intralesional

    Not yet recruiting
    • Plantar Wart
    • intralesional combined digoxin and furosemide
    • +2 more
    • (no location specified)
    Oct 25, 2022

    Hemophilia B Trial in Worldwide (FLT180a)

    Terminated
    Has Results
    • Hemophilia B
    • FLT180a
    • Memphis, Tennessee
    • +10 more
    Nov 8, 2022

    Multiple Myeloma Trial in Norway (Early treatment of relapse with carfilzomib, dexamethasone, daratumumab, Standard treatment of

    Recruiting
    • Multiple Myeloma
    • Early treatment of relapse with carfilzomib, dexamethasone, daratumumab
    • Standard treatment of relapse with carfilzomib, dexamethasone, daratumumab
    • Bergen, Norway
    • +12 more
    Jun 17, 2021

    Lung Cancer, Lung; Node Trial (CT scans 2D Reconstruction, CT scans 2D plus 3D Reconstruction)

    Not yet recruiting
    • Lung Cancer
    • Lung; Node
    • CT scans 2D Reconstruction
    • CT scans 2D plus 3D Reconstruction
    • (no location specified)
    Jan 27, 2023

    Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (Enzalutamide, Docetaxel, Prednisolone)

    Active, not recruiting
    Has Results
    • Metastatic Castration Resistant Prostate Cancer
    • Linz, Austria
    • +88 more
    Dec 22, 2022

    Basal Cell Carcinoma Trial in Maastricht (Punch biopsy (3mm))

    Completed
    • Basal Cell Carcinoma
    • Punch biopsy (3mm)
    • Maastricht, Limbrug, Netherlands
      Maastricht University Medical Center+
    Oct 12, 2022

    Serum NGAL IN Patients With Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma(MM)
    • SERUM NGAL
    • (no location specified)
    Jun 26, 2022

    Prevalence of Hyperprolactinemia in Systemic Scleroderma

    Recruiting
    • Sclerosis, Systemic
    • +2 more
    • blood test
    • Lille, France
      Hop Claude Huriez Chu Lille
    Oct 4, 2021

    Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue Trial in United States (FoundationOne Liquid CDx)

    Recruiting
    • Ewing Sarcoma
    • +6 more
    • FoundationOne Liquid CDx
    • Los Angeles, California
    • +14 more
    Oct 5, 2023

    Chronic Kidney Disease (CKD) Trial in New Haven, New York, Philadelphia (REGN5459, REGN5458)

    Not yet recruiting
    • Chronic Kidney Disease (CKD)
    • New York, New York
      New York University Langone Health - Transplant Institute
    Jul 11, 2022

    Carcinoid Tumor of the Small Bowel, Neuroendocrine Tumour Trial in Worldwide (Octreotide LAR, 177Lu-DOTA0-Tyr3-Octreotate)

    Completed
    Has Results
    • Carcinoid Tumor of the Small Bowel
    • Neuroendocrine Tumour
    • Los Angeles, California
    • +38 more
    Mar 10, 2022

    Endometriosis Trial in University Park (Salsalate Pill, Placebo)

    Recruiting
    • Endometriosis
    • Salsalate Pill
    • Placebo
    • University Park, Pennsylvania
      The Pennsylvania State University
    Dec 13, 2022

    Prostate Cancer, mCRPC Trial in Seoul (Lu-177-DGUL, Ga-68-NGUL)

    Recruiting
    • Prostate Cancer
    • mCRPC
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Sep 22, 2022

    Perianal Fistula, Crohn's Disease Trial (Human TH-SC01 cell injection)

    Not yet recruiting
    • Perianal Fistula
    • Crohn's Disease
    • Human TH-SC01 cell injection
    • (no location specified)
    Nov 15, 2022

    Advanced Retinitis Pigmentosa Trial in United States (RST-001)

    Active, not recruiting
    Has Results
    • Advanced Retinitis Pigmentosa
    • San Francisco, California
    • +3 more
    Sep 9, 2022

    Adjuvant Radiotherapy for pT1b Esophageal Cancer After

    Completed
    • Esophageal Cancer
      • Beijing, China
        National Cancer Center/Cancer Hospital, Chinese Academy of Medic
      Aug 10, 2022

      Advanced Malignancies Trial in Beijing (Recombinant Humanized Monoclonal Antibody MIL95)

      Recruiting
      • Advanced Malignancies
      • Recombinant Humanized Monoclonal Antibody MIL95
      • Beijing, China
        Beijing Cancer Hospital
      Feb 14, 2022